a multicenter phase ii study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
本文档由 gt8s4v 分享于2016-03-07 21:30
a multicenter phase ii study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
分享:
君,已阅读到文档的结尾了呢~~